Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

Abstract

Rivaroxaban was superior to enoxaparin for thromboprophylaxis after total knee arthroplasty, with similar rates of bleeding. (ClinicalTrials.gov number, NCT00361894.)

Keywords

MedicineRivaroxabanArthroplastyTotal knee arthroplastyEnoxaparin sodiumSurgeryThrombosisWarfarinLow molecular weight heparinInternal medicineAtrial fibrillation

Affiliated Institutions

Related Publications

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Gerhard Hindricks , Tatjana Potpara , Nikolaos Dagres +81 more

International audience

2020 European Heart Journal 9354 citations

Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation

Raphaël Rosenhek , Florian Rader , Ursula Klaar +6 more

Background— The management of asymptomatic severe mitral regurgitation remains controversial. The aim of this study was to evaluate the outcome of a watchful waiting strategy in...

2006 Circulation 508 citations

Natural History of Asymptomatic Mitral Valve Prolapse in the Community

Jean-François Aviérinos , Bernard J. Gersh , L. Joseph Melton +5 more

Background— The outcome of mitral valve prolapse (MVP) is controversial, with marked discrepancies in reported complication rates. Methods and Results— We conducted a community ...

2002 Circulation 438 citations

Publication Info

Year: 2008
Type: article
Volume: 358
Issue: 26
Pages: 2776-2786
Citations: 1286
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1286

OpenAlex

Cite This

APA Style

                            
                                
                                    Michael R. Lassen, 
                                
                                    Walter Ageno, 
                                
                                    Lars C. Borris
                                
                                et al.
                            
                            (2008). 
                            Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty. 
                            New England Journal of Medicine
                            , 358
                            (26)
                            , 2776-2786.
                            https://doi.org/10.1056/nejmoa076016
                        

Identifiers

DOI: 10.1056/nejmoa076016